Lung Cancer Study Group
N E W S – F I L E
Dr. Fernanda EstevinhoOncologist at Hospital Pedro Hispano – ULS MatosinhosSelected Article: “Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data” O artigo selecionado…
To celebrate this anniversary, we recall the GECP’s journey through the most used digital communication networks around the world.After our debut on Facebook and Instagram in May 2020, we created an institutional page on LinkedIn last year.At a time when…
Lung cancer is more than smoking” is the motto of the GECP campaign to mark the World No Tobacco Day, which is celebrated annually on the 31st of May.Today we focus on demystifying the stigma associated with lung cancer, warning…
GECP has just launched another digital initiative that aims to promote regular scientific updating and the sharing of ideas among peers. It is entitled “Selected Article” and gives voice to the members of the Scientific Committee of the GECP, inviting…
As part of the webinar “Lung Cancer: together for a more promising future”, a group of representatives from the Portuguese Pneumology Society (Prof. Dr. António Morais), from the Lung Cancer Study Group (Dr. Teresa Almodovar), from the Portuguese League Against…
On May 18, to mark the European Oncology Nursing Day, the Lung Cancer Study Group (GECP) and the Portuguese Oncology Nursing Association (AEOP) launched a tribute campaign to all oncologist nurses. To celebrate this date, we invited three nurses to…
The Hotel Vila Galé, in Coimbra, will host a meeting organized jointly by the Lung Cancer Study Group (GECP) and the Respiratory Diseases Study Group (GRESP) of the Portuguese Association of General and Family Medicine (APMGF), with support of the…
After the recent opening of two Early Access Programs (PAP) to tepotinib and amivantamab (see news here!) for the treatment of two subtypes of lung cancer, INFARMED granted the request for a PAP to nivolumab in combination with ipilimumab for…
Did you know that today, Thursday, April 7, is World Health Day? This year, to mark this date, the Lung Cancer Study Group will publish a digital campaign with tips to take care of lung health… and beyond! Accept the…
Recently, INFARMED opened two new Early Access to Medicines Programs (PAP) for the treatment of lung cancer, which allow access to innovative therapies in two subtypes: the insertion of exon 20 of the EGFR and the skipping of exon 14…
Next March 31 at 6 pm Pulmonale will hold another webinar, on the theme “The Importance of Early Diagnosis of Lung Cancer” In a dialogue moderated by journalist Vera Arreigoso, Dr. Barbara Parente and Dr. Fernanda Estevinho will be chatting…
Yesterday, March 19th, the Spring Meeting took place, aimed at GECP members. The chosen location was the Montebelo Vista Alegre Ílhavo Hotel. We appreciate everyone’s strong turnout, we had a full room and a very participatory audience. Very soon, we…
